Gov. Gavin Newsom wants to regulate out-of-control health care spending in California. The effort is being shaped by the very health industry players that would be regulated.
Category: Health Industry
Hospitals Confront Climate Change as Patients Sick From Floods and Fires Crowd ERs
Patients sickened in heat waves, flooding and wildfire have raised awareness of climate change’s impact on health. Now, some hospitals are building solar panels and cutting waste to reduce their own carbon footprints, with support from a new office at the U.S. Department of Health and Human Services. But the industry is moving slowly.
Biosimilar Drugs Are Cheaper Than Biologics. Are They Similar Enough to Switch?
Biologic drugs, made from living organisms, and the cheaper biosimilar drugs that mimic them are more complex than chemical drugs and their generic counterparts. The Food and Drug Administration says biosimilars are as safe and effective as the biologics, and doctors agree — but they are cautious about changing the treatment regimen of patients doing well.
KHN’s ‘What the Health?’: Much Ado About Drug Prices
Democrats have hit a snag in their effort to compile a $3.5 trillion social-spending bill this fall — moderates are resisting support for Medicare drug price negotiation provisions that would pay for many of the measure’s health benefit improvements. Meanwhile, the new abortion restrictions in Texas have moved the divisive issue back to the political front burner. Alice Miranda Ollstein of Politico, Rachel Cohrs of Stat and Shefali Luthra of The 19th join KHN’s Julie Rovner to discuss these issues and more. Also this week, Rovner interview’s KHN’s Phil Galewitz about the latest KHN-NPR “Bill of the Month” installment, about two similar jaw surgeries with very different price tags.